Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 2:1:283-287.
doi: 10.1016/j.ymgmr.2014.07.001. eCollection 2014.

Frequency of de novo mutations in Japanese patients with Fabry disease

Masahisa Kobayashi  1 , Toya Ohashi  2 , Sayoko Iizuka  3 , Eiko Kaneshiro  1 , Takashi Higuchi  3 , Yoshikatsu Eto  4 , Hiroyuki Ida  2
Affiliations

Frequency of de novo mutations in Japanese patients with Fabry disease

Masahisa Kobayashi et al. Mol Genet Metab Rep. .

Abstract

We examined alpha-galactosidase A (GLA) gene mutations in 74 Japanese families with Fabry disease (FD) to determine the frequency of de novo mutations. In 5 of 74 families (6.8%), the probands had no positive family histories and were diagnosed as de novo because their parents had no mutations in GLA gene. The parents of Fabry patients do not necessarily have mutations in GLA gene which is an important consideration in genetic counseling for FD.

Keywords: Alpha-galactosidase A; De novo mutation; Fabry disease; Genetic counseling; Novel mutation; W340S.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A. Study patients. B. The family trees of de novo cases. The probands of families 1, 2, 3 and 4 were classically affected male patients and that of family 5 was a female heterozygote patient. The parents of probands in these 5 families had no characteristic symptoms of FD. All of the probands had disease-causing mutations and these mutations were not detected from their parents and siblings.
See this image and copyright information in PMC

References

    1. Desnick R.J., Ioannou Y.A., Eng C.M. α-Galactosidase A deficiency: Fabry disease. In: Scriver C.R., Beaudet A.L., Sly W.S., Valle D., editors. The Metabolic and Molecular Basis of Inherited Disease. 8th ed. McGraw-Hill Inc.; New York: 2001. pp. 3733–3774.
    1. Meikle P.J., Hopwood J.J., Clague A.E., Carey W.F. Prevalence of lysosomal storage disorders. JAMA. 1999;281:249–254. - PubMed
    1. Spada M., Pagliardini S., Yasuda M., Tukel T., Thiagarajan G., Sakuraba H., Pnonzone A., Desnick R.J. High incidence of later onset Fabry disease revealed by newborn screening. Am. J. Hum. Genet. 2006;79:21–40. - PMC - PubMed
    1. Hwu W.L., Chien Y.H., Lee N.C., Chiang S.C., Dobrovolny R., Huang A.C., Yeh H.Y., Chao M.C., Lin S.H., Kitagawa T., Desnick R.J., Hsu L.W. Newborn screening for Fabry disease in Taiwan reveals a high incidence of the later-onset GLA mutation c.936 + 919G>A (IVS4 + 919G>A) Hum. Mutat. 2009;30:1397–1405. - PMC - PubMed
    1. Inoue T., Hattori K., Ihara K., Ishii A., Nakamura K., Hirose S. Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study. J. Hum. Genet. 2013;58:548–552. - PubMed

LinkOut - more resources